Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05374512 |
|---|---|
| Brief Title: | A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02) |
| First Submitted : | April 19, 2022 |
| First Submitted that Met QC Criteria : | May 10, 2022 |
| First Posted : | May 16, 2022 |
| Last Update Submitted that Met QC Criteria : | March 20, 2024 |
| Last Update Posted : | March 21, 2024 |